Gift or transfer — classified separately from trades.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 13, 2026
Reporting period
Not applicable
Filed with the SEC
May 16, 2026
OfficerGift / transfer
Context
Classification
gift transfer
Code G — gift, bequest or transfer
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-227411
Filed / recorded
May 16, 2026, 2:59 AM UTC
Added to OQRO
Oct 6, 2026, 7:14 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
CORCEPT THERAPEUTICS INC
Issuer CIK
1088856
Ticker
CORT
Reporting person
Gary Charles Robb
Relationship
Officer
Officer title
Chief Business Officer
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
May 13, 2026
Transaction code
G
Shares / units
5,300
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
24,487
Ownership form
Direct
Amendment
No
Footnotes from the filing
Includes 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, and 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Excludes 49,716 shares previously owned directly which were transferred to the Gary Charles Robb TTE Robb Revocable Trust.